According to the company, the availability of AuroraSpectroscopy will provide Aurora breast magnetic resonance imaging (MRI) the capability to perform in vivo breast MR spectroscopy (MRS) and MR spectroscopic imaging.
AuroraSpectroscopy was developed to supplement Aurora breast MRI by further improving the image specificity of this technology. The Aurora breast MRI remains the only FDA-cleared dedicated breast MRI system specifically designed for the detection, diagnosis and management of breast disease alone.
Olivia Cheng, president and CEO of Aurora Imaging Technology, said: “The introduction of AuroraSpectroscopy is another example of Aurora’s commitment to offering promising tools and technology to aid medical professionals in combating breast disease through early detection and improved treatment planning.”